NEW YORK, NY (PRWEB) December 4, 2014
Guidepoint Global, LLC, a leading international primary research firm serving institutional investors and corporations, will soon mark the eighth anniversary of its US Breast Implant Market TRACKER. Launched January 2007 in conjunction with two additional aesthetics market-focused data sets – the US Dermal Fillers and the US Neurotoxins TRACKERs – the Breast Implant Market TRACKER delivers monthly web-based access to business and competitive insight such as market share and volume growth by manufacturer and product.
Guidepoint’s US Breast Implant TRACKER aggregates monthly implant data reported by a same-site panel comprising anonymous respondents representing approximately 2% of US market demand. Since inception, Guidepoint’s US Breast Implant market size, market share, and other market data including insights on saline vs. silicone and shaped vs. round, has provided users with visibility into the market dynamics of breast implants. Aesthetics volume and growth data is highly correlated with product sales figures reported by leading manufacturers. Collectively, the US Breast Implant, US Dermal Filler, and US Neurotoxin TRACKERs capture data identifying usage trends of products manufactured by Allergan, JNJ/Mentor, Sientra, Nestle/Galderma, Artes/Suneva, Merz, Sanofi-Aventis, Anika, Enhancement Medical, and others.
US Breast Implant utilization data, provided by US-based implanters, provides a real-world perspective on the effect of evolving market dynamics. Since inception, Guidepoint clients have used TRACKER data to get an early understanding of trends such as:
Market share by manufacturers
The significant downturn of volume at the end of 2008, continued recession in 2009, and eventual recovery in 2010
The change in market share between silicone and saline implants
Overall market share of round vs. anatomical shaped implants
Looking forward to 2015, David Hill, CIO and Acting Director of Guidepoint’s TRACKER Team, said, “It will be interesting to see how market shares of the major implant manufacturers play out in light of varied end market preference for texturing, shape, and silicone vs. saline fill, especially in the presence of a relatively newer competitor.”
ABOUT GUIDEPOINT TRACKER
Guidepoint’s TRACKER equips institutional investors and manufacturers with monthly volume, market share, pricing, and other commercial insight into medical device and biopharmaceutical utilization reported by representative, anonymous, same-site samples.
Guidepoint’s TRACKER data and market models are exclusively available to Guidepoint clients via a secure, web-based platform
ABOUT GUIDEPOINT
Guidepoint Global is a leading primary research firm that provides on-demand access to a highly vetted global network of industry experts. Founded in 2003, Guidepoint covers all sectors, geographies, and relevant roles. Sector expertise includes healthcare, technology, media, telecommunications, energy, industrials, consumer goods & services, and financial services. Clients include some of the world’s leading private equity firms, multinational corporations, consulting firms, and institutional investors.
Guidepoint Global offers primary research services with its network of Advisors via telephone consultations, face-to-face meetings, custom surveys, and proprietary data products. These services, coupled with an industry-leading compliance platform, provide the insight required to make more informed and efficient business decisions.